Promoting and strengthening Pharma Biotechnology in Europe is the objective of EAPB. Therefore it makes sense to extend our capacity by collaboration with other international and national associations, which you find directly linked to this website.
The European Federation of Biotechnology is the non-profit association of Learned Societies, Universities, Institutes, Companies and Individuals interested in the promotion of Biotechnology throughout Europe and beyond.
The American Association of Pharmaceutical Scientists - AAPS - provides a dynamic international forum for the exchange of knowledge among scientists to enhance their contributions to health. We offer timely scientific programs, ongoing education, opportunities for networking, and professional development.
MEGRA (MittelEuropäische Gesellschaft für Regulatorische Angelegenheiten- Society for Regulatory Affairs in Central Europe) represents a panel of experts - predominantly from German-speaking countries - who are professionals in the authorities administered and regulated topics of drugs, medicinal products, diagnostics and adjacent areas of expertise.
TOPRA is the global organisation for Regulatory Affairs professionals and for those who have an interest in Regulatory Affairs in the healthcare sector. Our current membership is drawn from over 40 countries and members worldwide are actively involved in delivering the services needed by busy regulatory specialists. Members are drawn from industry, the regulatory agencies and the consultancy community and work in all sectors including medical technologies, biotech, borderline products and pharmaceuticals.
European Biotechnology Network
The European Biotechnology Network and EAPB are collaborating as both organisations share some targets, visions and ideas so that the collaboration can gain mutual benefit for members of both associations.
European Biotechnology Network is dedicated to facilitating co-operation between professionals in biotechnology and the life sciences all over Europe. The network is run by the European Biotechnology Foundation, a non-profit organisation based in Brussels.
The first project of EBN and EAPB is about funding opportunities for biotech SMEs in Europe. The Funding Hub, which is currently focussed on the launch of FP7 calls, with the two stage health call offering a great opportunity for biotechs to drive proposals. The health call information will be followed by detailed analysis of agbio, nanotech and industrial opportunities later in August.
European Society of Biochemical Engineering Sciences
The European Society of Biochemical Engineering Sciences stimulates scientific advances in the field of biochemical engineering and provides a platform for communication, education and interdisciplinary exchange. ESBES serves as an interface between industry and academia and fosters cooperation of bioengineers from all over Europe.
EAPB is cooperating with several national biotechnology associations in Europe.
AFI (Associazione Farmaceutici dell' Industria) is a leading Italian scientific association based in Milan, whose members are scientists and professionals operating in pharmaceutical industry, scientific institutes, academia, public agencies or in companies providing services or instrumentation to the pharmaceutical compartment. Also companies operating in these areas can be member of AFI.
Bio Deutschland is an independent biotechnology association representing Germany's biotechnology industry. It wants to support and catalyse the establishment of an innovative and well-financed industry sector within the German economy on the basis of modern biosciences. One of the association's aims is to position Germans biotechnology industry internationally.
is the new Italian innovation cluster dedicated to bio and medical technologies created thanks to the intervention of Regione Piemonte.
It gathers 67 companies, research centres and three academic institutions (Università di Torino, Università del Piemonte Orientale and Politecnico di Torino), who signed an agreement to create, build, support and animate the local cluster.
The initiative is led by Bioindustry Park Silvano Fumero, the local science & technology park founded in 1998 which, since its creation, worked as system integrator for the development of Life Sciences in the region.
In coherence with the European Union recommendations, bioPmed works to stimulate innovative activity by promoting intensive interactions, sharing of facilities and exchange of knowledge and expertise and by contributing effectively to technology transfer, networking and information dissemination among the undertakings in the cluster.
BioRegioN is a state initiative of Lower Saxony for the development of biotechnology and biomedical engineering. Lower Saxony's Life Science excellence is evident especially in Infection Research, Neurobiology, "Omics" and Diagnostics and on the other hand, biomedical engineering, regenerative medicine and implant technologies. The main objective is to intensify the network structures between companies, scientists, health funds, hospitals, associations and other partners in Life Sciences and the health sector in order to promote innovation and progress in these sectors.
BIOPRO Baden-Württemberg provides targeted support to research institutions and companies in the biotechnology and life sciences sectors to optimally position the strengths of this leading biotechnology location on the national and international level. To optimize international networking and business opportunities BIOPRO cooperates with EAPB.
BioRegion Rhine Neckar
Rhine Neckar BioCluster is located in Baden Württemberg, in the Southwest of Germany.
The BioRegion Rhine Neckar supports innovative ideas and services of its members. Main target is to realize development programmes in tight cooperation with national and regional institutions, companies and research institutes to foster and enable a vibrant biotechnology environment with excellent opportunities for education, research and business.
Founded in 2005, the Medicen Paris Region competitiveness biocluster aims to drive the Paris Region as a famous European cluster in the industrial perspectives as well as in innovative technologies for healthcare diagnostics and therapeutics.
Medicen's objectives are facilitating access to innovation, increasing the transfer of innovation from the research sector to the industrial sector, accelerating time to market of therapeutic and/or technological innovations beneficial to patients, international notoriety and visibility development of Paris Region's Biocluster.
OBN is the premier not-for-profit biobusiness network supporting growth and development of the UK's bioindustry. Headquartered in the heart of the Oxford biocluster, OBN provides international networking and partnering opportunities at its annual flagship biopartnering conference, BioTrinity (www.biotrinity.com) every April.